$5.24 +0.39 (8.04%)

Rain Enhancement Technologies Holdco, Inc. Class A Common Stock (RAIN)

Rain Enhancement Technologies Holdco, Inc. Class A (RAIN) is a company focused on developing and commercializing advanced weather modification and enhancement technologies. It aims to leverage innovative solutions to improve rainfall, manage water resources, and address environmental challenges through proprietary platforms and scientific approaches.

đźš« Rain Enhancement Technologies Holdco, Inc. Class A Common Stock does not pay dividends

Company News

Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights
GlobeNewswire Inc. • Rain Oncology Inc. • December 13, 2023

NEWARK, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos”) will acquire Rain for $1.16 in cash per share plus a non-tradeable contingent value right (a “CVR”) for potential cash payments of up to approximately $0.17 per share.

3 Top Penny Stocks to Buy According To Insiders In October
PennyStocks • J. Samuel • October 16, 2023

Penny stocks to buy according to insiders. The post 3 Top Penny Stocks to Buy According To Insiders In October appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Rain Oncology And 3 Other Stocks Under $1 Insiders Are Buying
Benzinga • Lisa Levin • October 16, 2023

The Dow Jones closed slightly higher on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Parks! America The Trade: Parks! America, Inc. (OTC: PRKA) Director Charles Kohnen acquired a total of 100,000 shares an average price of $0.40. To acquire these shares, it cost around $40,000. What’s Happening: Total revenues for the fiscal quarter ended July 2, 2023 fell to $2.85 million, from $3.64 million for the fiscal quarter ended July 3, 2022. What ...

Why Shares of Rain Oncology Are Plummeting Today
The Motley Fool • [email protected] (Jim Halley) • May 22, 2023

The company released disappointing top-line results for its lead oncology therapy.

Wall Street Breakfast: The Week Ahead
Seeking Alpha • Wall Street Breakfast • October 17, 2021

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.